Universal Vision Biotechnology Co

Universal Vision Biotechnology Co Net Margin

The Net Profit Margin of Universal Vision Biotechnology Co (3218.TWO) as of Oct 19, 2026 is 24.80 %. In the previous year, Net Profit Margin was 25.18 % — a change of -1.51% (lower).

Net Margin

24.80 %

YoY

-1.51%

Last updated:

Net Profit Margin of Universal Vision Biotechnology Co is 2025 24.80 % . Net Profit Margin of Universal Vision Biotechnology Co was 2024 25.18 % . It decreases by -1.51% lower compared to the previous year.

For Universal Vision Biotechnology Co, the net margin of 24.8% is up versus 22.6% a few years ago.

The Universal Vision Biotechnology Co Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
13.51 TWD
Jan 1, 2019
16.77 TWD
Jan 1, 2020
23.54 TWD
Jan 1, 2021
22.62 TWD
Jan 1, 2022
24.34 TWD
Jan 1, 2023
25.60 TWD
Jan 1, 2024
25.18 TWD
Jan 1, 2025
24.80 TWD
The Universal Vision Biotechnology Co Net Margin history
YEARNet MarginYoY
24.80 %-1.51%
25.18 %-1.64%
25.60 %+5.17%
24.34 %+7.59%
22.62 %-3.87%
23.54 %+40.32%
16.77 %+24.12%
13.51 %+21.81%
11.09 %+29.67%
8.56 %+7.04%
7.99 %-22.21%
10.28 %+10,044.35%
0.10 %+201.01%
0.03 %-78.11%
0.15 %-23.38%
0.20 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Universal Vision Biotechnology Co Stock analysis

What does Universal Vision Biotechnology Co do? Universal Vision Biotechnology Co Ltd, listed on the Taiwan Stock Exchange under ticker 3218.TWO, is a company operating in the Health Care sector. Headquartered in Taipei City, Taiwan, the company has 404 employees. It went public on January 29, 2004. Universal Vision Biotechnology focuses on the sale of optical instruments, glasses, and contact lenses. The company also provides laser vision correction equipment and services, as well as medical cosmetology services. Its operations are primarily concentrated in the Taiwan market. The company's website is https://www.eyedoctor.com.tw/. Universal Vision Biotechnology does not engage in the sale of glass ornaments or the trading of medical drugs, as these details were incorrectly mentioned in the source description. The company is involved in the leasing of medical facilities and the planning of clinic operations, but it does not provide services related to the leasing of medical places or the trading of medical drugs. The company's business activities are centered around optical and medical services within Taiwan. Universal Vision Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Universal Vision Biotechnology Co stock

Net Profit Margin of Universal Vision Biotechnology Co is 24.80 % in 2025.

Net Profit Margin of Universal Vision Biotechnology Co changed from 25.18 % to 24.80 %, representing a -1.51% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Universal Vision Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Universal Vision Biotechnology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Universal Vision Biotechnology Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Universal Vision Biotechnology Co